Lahore Medical Research Center, LLP
Quick facts
Phase 3 pipeline
- Ibuprofen and Aprepitant · Oncology; Pain Management
This combination uses ibuprofen to reduce inflammation and pain via COX inhibition, while aprepitant blocks substance P receptors to prevent nausea and vomiting.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Lahore Medical Research Center, LLP portfolio CI brief
- Lahore Medical Research Center, LLP pipeline updates RSS
Frequently asked questions about Lahore Medical Research Center, LLP
What is Lahore Medical Research Center, LLP's pipeline?
Lahore Medical Research Center, LLP has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Ibuprofen and Aprepitant.
Related
- Sector hub: All tracked pharma companies